Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

25 Sept 2023

Abstract excerpt

BACKGROUND: Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various physiological and pathological functions by post-transcriptional regulation of gene expression being considered markers for many diseases including diabetes and dyslipidemia. We aimed to identify new common miRNAs both in MVs and plasma that could be predictive biomarkers for diabetic dyslipidemia evolution. METHODS: For this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Extracellular vesicles in disease
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37749569
DOI: 10.1186/s12933-023-01988-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potentialPMID 37749569Read ↗

<p>Circulating miR-15a and miR-222 as Potential Biomarkers of Type 2 Diabetes</p>Semantic proximity Read ↗

Emerging roles of microRNAs as diagnostics and potential therapeutic interest in type 2 diabetes mellitusSemantic proximity Read ↗

A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV studySemantic proximity Read ↗

Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patientsSemantic proximity Read ↗

Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic DiseasesSemantic proximity Read ↗

Circulating microRNA Biomarkers of Diabetic RetinopathySemantic proximity Read ↗

Circulating miRNA expression in long-standing type 1 diabetes mellitusSemantic proximity Read ↗

Insights into the Diagnostic Potential of Extracellular Vesicles and their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular ComplicationsSemantic proximity Read ↗

A Review of MicroRNAs and lncRNAs in Atherosclerosis as Well as Some Major Inflammatory Conditions Affecting AtherosclerosisSemantic proximity Read ↗

MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related ComplicationsSemantic proximity Read ↗

Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity BiomarkersSemantic proximity Read ↗

Extracellular vesicles—incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.